Subscribe To Our Free Newsletter |
Jubilant Pharmova declines after US FDA issues 4 observations to Roorkee facility
Jubilant Pharmova slipped 2.14% to Rs 581.00 after the company announced the completion of USFDA audit of Solid dosage manufacturing facility at Roorkee with 4 observations.